{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T18:26:31Z","timestamp":1770229591834,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T00:00:00Z","timestamp":1649808000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T00:00:00Z","timestamp":1649808000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008375","name":"Universit\u00e4t Basel","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008375","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antimicrob Resist Infect Control"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The optimal extent of screening of contact patients (CoPat) after exposure to patients infected or colonized with vancomycin-resistant enterococci (VRE) remains controversial.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We retrospectively developed a new risk stratification for screening patients exposed to VRE, based on data from three outbreaks\u2014two with <jats:italic>Enterococcus faecium vanB<\/jats:italic> and one with <jats:italic>Enterococcus faecium vanA<\/jats:italic> involving 1096 CoPat\u2014in a low endemic setting. We classified them into four risk groups: three on environmental exposure, one by healthcare exposure: high (sharing the same room\/bathroom with a VRE-colonized patient), medium (hospitalization in the same room after a VRE-colonized patient\u2019s discharge until terminal disinfection including ultraviolet C (UVc)-disinfection), low (hospitalized in the same room within three weeks before the VRE-colonized patient), and \u201cstaff\u201d (screening of patients having the same medical care team).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>VRE-transmission occurred in 7.9% in the high-risk group compared to 0.6% and 0% in the medium and low risk groups. There was a significant trend to higher rates of transmission by risk level of exposure (p\u2009&lt;\u20090.001). In the \u201cstaff\u201d group, VRE transmission rate was 2.3%.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Based on this stratification, we recommend to focus screening of exposed CoPat on the high-risk and \u201cstaff\u201d group, saving resources and costs, but larger studies will allow to further improve the yield of VRE screening in the outbreak setting.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13756-022-01089-9","type":"journal-article","created":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T13:02:47Z","timestamp":1649854967000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Patients exposed to vancomycin-resistant enterococci during in-hospital outbreaks in a low endemic setting: a proposal for risk-based screening"],"prefix":"10.1186","volume":"11","author":[{"given":"Andrea C.","family":"B\u00fcchler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvio","family":"Ragozzino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Wicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Violeta","family":"Spaniol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sammy","family":"J\u00e4ger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena M. B.","family":"Seth-Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Goldenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimira","family":"Hinic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Egli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reno","family":"Frei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7661-5824","authenticated-orcid":false,"given":"Andreas F.","family":"Widmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,13]]},"reference":[{"key":"1089_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2807\/1560-7917.ES.2020.25.35.1900575","volume":"25","author":"V Piezzi","year":"2020","unstructured":"Piezzi V, Gasser M, Atkinson A, Kronenberg A, Vuichard-Gysin D, Harbarth S, et al. Increasing proportion of vancomycin-resistance among enterococcal bacteraemias in Switzerland: a 6-year nation-wide surveillance, 2013 to 2018. Euro Surveill. 2020;25:1\u20139.","journal-title":"Euro Surveill"},{"key":"1089_CR2","unstructured":"CDC CSG. https:\/\/www.cdc.gov\/hai\/pdfs\/containment\/Health-Response-Contain-MDRO-H.pdf. Accessed 19 Jan 2022."},{"key":"1089_CR3","unstructured":"Vuichard-Gysin D, Schlegel M, Troillet N, Senn L, Marschall J, Blanc D, et al. Temporary expert guidance for healthcare institutions to contain the spread of vancomycin- resistant enterococci (VRE ) in Switzerland. VRE Taskforce Swissnoso. 2018. https:\/\/www.swissnoso.ch\/fileadmin\/swissnoso\/Dokumente\/1_Swissnoso_allgemein\/180912_Temporary_expert_guidance_for_healthcare_institutions_to_contain_the_spread_of_VRE_final_1.0.pdf."},{"key":"1089_CR4","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2018.23.29.1800351","author":"N Wassilew","year":"2018","unstructured":"Wassilew N, Seth-Smith HM, Rolli E, Fietze Y, Casanova C, F\u00fchrer U, et al. Outbreak of vancomycin-resistant Enterococcus faecium clone ST796, Switzerland, December 2017 to April 2018. Euro Surveill. 2018. https:\/\/doi.org\/10.2807\/1560-7917.ES.2018.23.29.1800351.","journal-title":"Euro Surveill"},{"key":"1089_CR5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13756-019-0466-x","volume":"8","author":"N Buetti","year":"2019","unstructured":"Buetti N, Wassilew N, Rion V, Senn L, Gardiol C, Widmer A, et al. Emergence of vancomycin-resistant enterococci in Switzerland: a nation-wide survey. Antimicrob Resist Infect Control. 2019;8:16. https:\/\/doi.org\/10.1186\/s13756-019-0466-x.","journal-title":"Antimicrob Resist Infect Control"},{"key":"1089_CR6","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1093\/jac\/dkt525","volume":"69","author":"G De Angelis","year":"2014","unstructured":"De Angelis G, Cataldo MA, De Waure C, Venturiello S, La Torre G, Cauda R, et al. Infection control and prevention measures to reduce the spread of vancomycin-resistant enterococci in hospitalized patients: a systematic review and meta-analysis. J Antimicrob Chemother. 2014;69:1185\u201392. https:\/\/doi.org\/10.1093\/jac\/dkt525.","journal-title":"J Antimicrob Chemother"},{"key":"1089_CR7","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1001\/jama.2013.277815","volume":"310","author":"AD Harris","year":"2013","unstructured":"Harris AD, Pineles L, Belton B, Johnson JK, Shardell M, Loeb M, et al. Universal glove and gown use and acquisition of antibiotic-resistant bacteria in the ICU. JAMA. 2013;310:1571\u201380. https:\/\/doi.org\/10.1001\/jama.2013.277815.","journal-title":"JAMA"},{"key":"1089_CR8","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1016\/j.ajic.2018.05.003","volume":"46","author":"J Johnstone","year":"2018","unstructured":"Johnstone J, Chen C, Rosella L, Adomako K, Policarpio ME, Lam F, et al. Patient- and hospital-level predictors of vancomycin-resistant Enterococcus (VRE) bacteremia in Ontario, Canada. Am J Infect Control. 2018;46:1266\u201371. https:\/\/doi.org\/10.1016\/j.ajic.2018.05.003.","journal-title":"Am J Infect Control"},{"key":"1089_CR9","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1017\/ice.2018.57","volume":"39","author":"G Bearman","year":"2018","unstructured":"Bearman G, Abbas S, Masroor N, Sanogo K, Vanhoozer G, Cooper K, et al. Impact of discontinuing contact precautions for methicillin-resistant staphylococcus aureus and vancomycin-resistant enterococcus: an interrupted time series analysis. Infect Control Hosp Epidemiol. 2018;39:676\u201382.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1089_CR10","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ajic.2017.08.031","volume":"46","author":"AR Marra","year":"2018","unstructured":"Marra AR, Edmond MB, Schweizer ML, Ryan GW, Diekema DJ. Discontinuing contact precautions for multidrug-resistant organisms: a systematic literature review and meta-analysis. Am J Infect Control. 2018;46:333\u201340. https:\/\/doi.org\/10.1016\/j.ajic.2017.08.031.","journal-title":"Am J Infect Control"},{"key":"1089_CR11","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1017\/ice.2018.93","volume":"39","author":"EM Martin","year":"2018","unstructured":"Martin EM, Bryant B, Grogan TR, Rubin ZA, Russell DL, Elashoff D, et al. Noninfectious hospital adverse events decline after elimination of contact precautions for MRSA and VRE. Infect Control Hosp Epidemiol. 2018;39:788\u201396.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1089_CR12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1017\/ice.2017.258","volume":"39","author":"JA Roth","year":"2018","unstructured":"Roth JA, Hornung-Winter C, Radicke I, Hug BL, Biedert M, Abshagen C, et al. Direct costs of a contact isolation day: a prospective cost analysis at a Swiss University Hospital. Infect Control Hosp Epidemiol. 2018;39:101\u20133.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1089_CR13","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1086\/500322","volume":"42","author":"EM Mascini","year":"2006","unstructured":"Mascini EM, Troelstra A, Beitsma M, Blok HEM, Jalink KP, Hopmans TEM, et al. Genotyping and preemptive isolation to control an outbreak of vancomycin-resistant Enterococcus faecium. Clin Infect Dis. 2006;42:739\u201346. https:\/\/doi.org\/10.1086\/500322.","journal-title":"Clin Infect Dis"},{"key":"1089_CR14","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1017\/ice.2017.268","volume":"39","author":"DJ Anderson","year":"2018","unstructured":"Anderson DJ, Knelson LP, Moehring RW, Lewis SS, Weber DJ, Chen LF, et al. Implementation lessons learned from the benefits of enhanced terminal room (BETR) disinfection study: process and perceptions of enhanced disinfection with ultraviolet disinfection devices. Infect Control Hosp Epidemiol. 2018;39:157\u201363.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1089_CR15","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/nbt.2522","volume":"31","author":"S J\u00fcnemann","year":"2013","unstructured":"J\u00fcnemann S, Sedlazeck FJ, Prior K, Albersmeier A, John U, Kalinowski J, et al. Updating benchtop sequencing performance comparison. Nat Biotechnol. 2013;31:294\u20136.","journal-title":"Nat Biotechnol"},{"key":"1089_CR16","doi-asserted-by":"publisher","first-page":"3788","DOI":"10.1128\/JCM.01946-15","volume":"53","author":"M De Been","year":"2015","unstructured":"De Been M, Pinholt M, Top J, Bletz S, Mellmann A, Van Schaik W, et al. Core genome multilocus sequence typing scheme for high-resolution typing of enterococcus faecium. J Clin Microbiol. 2015;53:3788\u201397.","journal-title":"J Clin Microbiol"},{"issue":"116","key":"1089_CR17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jhin.2021.07.002","volume":"11","author":"AC B\u00fcchler","year":"2021","unstructured":"B\u00fcchler AC, Dangel M, Tschudin-sutter S, Widmer AF. Does high adherence to contact precautions lead to low in-hospital transmission of multi-drug-resistant micro-organisms in the endemic setting? J Hosp Infect. 2021;11(116):53\u20139. https:\/\/doi.org\/10.1016\/j.jhin.2021.07.002.","journal-title":"J Hosp Infect"},{"key":"1089_CR18","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1186\/s12877-019-1398-2","volume":"19","author":"B Mathis","year":"2019","unstructured":"Mathis B, Ha\u00efne M, Girard R, Bonnefoy M. Risk factors for vancomycin-resistant enterococcus acquisition during a large outbreak in patients aged 65 years and older. BMC Geriatr. 2019;19:377. https:\/\/doi.org\/10.1186\/s12877-019-1398-2.","journal-title":"BMC Geriatr"},{"key":"1089_CR19","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jiph.2016.04.010","volume":"10","author":"L Fossi Djembi","year":"2017","unstructured":"Fossi Djembi L, Hodille E, Chomat-Jaboulay S, Coudrais S, De Santis N, Gardes S, et al. Factors associated with Vancomycin-resistant Enterococcus acquisition during a large outbreak. J Infect Public Health. 2017;10:185\u201390. https:\/\/doi.org\/10.1016\/j.jiph.2016.04.010.","journal-title":"J Infect Public Health"},{"key":"1089_CR20","doi-asserted-by":"publisher","first-page":"e240","DOI":"10.1016\/j.ijid.2012.09.019","volume":"17","author":"KM Sohn","year":"2013","unstructured":"Sohn KM, Peck KR, Joo EJ, Ha YE, Kang CI, Chung DR, et al. Duration of colonization and risk factors for prolonged carriage of vancomycin-resistant enterococci after discharge from the hospital. Int J Infect Dis. 2013;17:e240\u20136. https:\/\/doi.org\/10.1016\/j.ijid.2012.09.019.","journal-title":"Int J Infect Dis"}],"container-title":["Antimicrobial Resistance &amp; Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-022-01089-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13756-022-01089-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-022-01089-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T17:10:07Z","timestamp":1649956207000},"score":1,"resource":{"primary":{"URL":"https:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-022-01089-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,13]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1089"],"URL":"https:\/\/doi.org\/10.1186\/s13756-022-01089-9","relation":{},"ISSN":["2047-2994"],"issn-type":[{"value":"2047-2994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,13]]},"assertion":[{"value":"13 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All data was collected as routine surveillance and therefore, no ethical approval was required by the local ethical committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participant"}},{"value":"Patients with a refused general consent were excluded from the analysis.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"60"}}